Researchers develop combined data model to better evaluate for mild cognitive impairment

October 4, 2018, Boston University School of Medicine

A new study has shown that by combining imaging and neuropsychological testing, one can more accurately assess the cognitive status of individuals.

Cognitive decline is one of the most concerning behavioral symptoms associated with Alzheimer's disease (AD). The ability to efficiently distinguish individuals with (MCI) from individuals who have normal cognition (NC) is crucial for early detection of AD.

In the past, different tests have been used to evaluate MCI. The Mini-Mental State Examination (MMSE) is a commonly used screening tool for dementia. Additionally, the Wechsler Memory Scale Logical memory (LM) test is a neuropsychological test that assesses verbal memory and is considered sensitive for AD. Neuroimaging, such as (MRI) provide biologic evidence that is neurodegenerative.

Researchers from Boston University School of Medicine (BUSM) used the National Alzheimer's Coordinating Center database to select data from 386 subjects who were clinically diagnosed with either NC or MCI. Subjects had previously completed the MMSE, the LM test and an MRI. They then developed a machine learning framework that allowed for the combination of models generated from individual MRI scans along with models developed on MMSE and LM test results to predict clinical diagnosis of . "Our findings indicate that this framework can better predict MCI as it has the capability to combine needed information from multimodal data resource," explained corresponding author Vijaya B. Kolachalama, Ph.D., assistant professor of medicine at BUSM.

According to Kolachalama and Rhoda Au, Ph.D., professor of anatomy and neurobiology at BUSM and director of neuropsychology at the Framingham Heart Study, this study is a proof of principle that multimodal fusion of models developed using MRI scans, and other traditional test data is feasible and can better predict cognitive impairment. The fusion was superior to the individual models alone and achieved an overall accuracy of over 90 percent.

These findings appear online in Alzheimer's & Dementia: Diagnosis, Assessment & Disease Monitoring.

Explore further: Evaluation and treatment of depression may reverse memory and cognitive difficulties

Related Stories

Evaluation and treatment of depression may reverse memory and cognitive difficulties

March 27, 2018
Individuals with worse depression and mood symptoms are more likely to develop Mild Cognitive Impairment (MCI) and to progress from MCI to dementia. Evaluation and treatment of symptoms of depression may improve or maintain ...

Clock drawing cognitive test should be done routinely in patients with high blood pressure

August 27, 2018
A clock drawing test for detecting cognitive dysfunction should be conducted routinely in patients with high blood pressure, according to research presented today at ESC Congress 2018.

Memory scores limited as Alzheimer's screening tool

December 4, 2017
(HealthDay)—Low memory scores are an early marker of amyloid positivity, but have limited value as a screening measure for early Alzheimer's disease among persons without dementia, according to a study published online ...

VAT score improves predictive value of MMSE for dementia

August 17, 2018
(HealthDay)—Administering the Visual Association Test (VAT) improves the predictive value of the Mini-Mental State Examination (MMSE) score for dementia, according to a study published in a recent issue of the Annals of ...

The role of verb fluency in the detection of early cognitive impairment in Alzheimer's disease

March 16, 2018
The ability to generate spoken verbs in infinitive in a given time begins to worsen in the early stages of Alzheimer's disease (AD). Thus, the verb fluency test has been found to be a suitable neuropsychological tool for ...

Recommended for you

Does diabetes damage brain health?

December 14, 2018
(HealthDay)—Diabetes has been tied to a number of complications such as kidney disease, but new research has found that older people with type 2 diabetes can also have more difficulties with thinking and memory.

Amyloid pathology transmission in lab mice and historic medical treatments

December 13, 2018
A UCL-led study has confirmed that some vials of a hormone used in discontinued medical treatments contained seeds of a protein implicated in Alzheimer's disease, and are able to seed amyloid pathology in mice.

Study links slowed brainwaves to early signs of dementia

December 13, 2018
To turn back the clock on Alzheimer's disease, many researchers are seeking ways to effectively diagnose the neurodegenerative disorder earlier.

New discoveries predict ability to forecast dementia from single molecule

December 11, 2018
Scientists who recently identified the molecular start of Alzheimer's disease have used that finding to determine that it should be possible to forecast which type of dementia will develop over time—a form of personalized ...

Researchers classify Alzheimer's patients in six subgroups

December 5, 2018
Researchers studying Alzheimer's disease have created an approach to classify patients with Alzheimer's disease, a finding that may open the door for personalized treatments.

Neuroscientists pinpoint genes tied to dementia

December 3, 2018
A UCLA-led research team has identified genetic processes involved in the neurodegeneration that occurs in dementia—an important step on the path toward developing therapies that could slow or halt the course of the disease. ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.